BLRX 배당금: BioLineRx Ltd. 수익률 인사이트



배당금

BLRX 배당금

BioLineRx Ltd.

$3.1

-7.46%

$-0.25

종가: May 07, 16:00:00 GMT-4

$3.1

애프터마켓: May 07, 20:00:00 GMT-4

개요 예보 수입 배당금 재무사항

주요 통계

이전 종가

$3.35

시가

$3.29

일일 범위

$3.1 - $3.33

52주 범위

$2.15 - $7.77

거래량

13.5K

평균 거래량

18.3K

배당수익률

EPS(TTM)

0.00

시가총액

$13.4M

BioLineRx Ltd.란 무엇인가요?

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.